Rafi Allos

General Court Annuls Additional Year Of Marketing Protection For Biogen's Tecfidera

UK Will Permanently Retain Its UK+ Exhaustion Regime To Allow Continued Supply Of Medicines Into The UK

AstraZeneca Refused Interim Injunction On SPC For Blockbuster Diabetes Treatment Against Glenmark But Swiftly Obtains Permission To Appeal

A New Approach To Regulation By The MHRA And NICE

UPC Revocation Actions: What Is A Reasonable Number Of Auxiliary Requests?